Louise Rodino-Klapac
President, R&D and Tech Ops · 4 filings · Latest: Mar 11, 2026
Sarepta Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SRPT | Louise Rodino-Klapac | President, R&D and Tech Ops | Mar 1, 2026 | Option Exercise | — | 8,125 | — | 232,155 |